Eslicarbazepine acetate: A therapeutic agent of paramount importance in acute anticonvulsant therapy

Eslicarbazepine acetate: A therapeutic agent of paramount importance in acute anticonvulsant therapy

Eslicarbazepine acetate (ESL) is a new, once daily, orally administered, third generation antiepileptic drug which is indicated in the treatment of partial-onset seizures. ESL is known to exert it’s anticonvulsant effect by blocking the voltage-gated sodium channels. Several clinical trials and phar...

Full description

Bibliographic Details
Main Authors: Farah Iram, Shah Alam Khan, Aftab Ahmad, Anees A Siddiqui, Asif Husain
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Acute Disease
Subjects:
Eslicarbazepine acetate
Partial-onset seizures
Epilepsy
Antiepileptic drugs
Drug interactions
Online Access:http://www.jadweb.org/article.asp?issn=2221-6189;year=2017;volume=6;issue=6;spage=245;epage=254;aulast=Iram

Internet

http://www.jadweb.org/article.asp?issn=2221-6189;year=2017;volume=6;issue=6;spage=245;epage=254;aulast=Iram

Similar Items